Elucidating Uncertainty in Heat Vulnerability Mapping: Perspectives on Impact Variables and Modeling Approaches.

Heat vulnerability maps are vital for identifying at-risk areas and guiding interventions, yet their relationship with health outcomes is underexplored. This study investigates the uncertainty in heat vulnerability maps generated using health outcomes and various statistical models. We constructed vulnerability maps for 167 municipalities in Korea, focusing on the mild and severe health impacts of heat waves on morbidity and mortality. The outcomes included incidence rates of heat-related outpatient visits (morbidity) and attributable mortality rates (mortality) among individuals aged 65 years and older. To construct these maps, we utilized 11 socioeconomic variables related to population, climate, and economic factors. Both linear and nonlinear statistical models were employed to assign these socioeconomic variables to heat vulnerability. We observed variations in the crucial socioeconomic variables affecting morbidity and mortality in the vulnerability maps. Notably, nonlinear models depicted the spatial patterns of health outcomes more accurately than linear models, considering the relationship between health outcomes and socioeconomic variables. Our findings emphasize the differences in the spatial distribution of heat vulnerability based on health outcomes and the choice of statistical models. These insights underscore the importance of selecting appropriate models to enhance the reliability of heat vulnerability maps and their relevance for policy-making.

Assessing heatwave effects on disabled persons in South Korea.

This study investigated the risk of heatwaves for people with disabilities and other socioeconomic attributes using Health Care Bigdata in South Korea. The Health Care Bigdata provides detailed information on heat-related illness (HRI) patients in 2011-2020 from seven major cities. We employed the Distributed Lag Nonlinear Model (DLNM) to measure heat waves' relative risk. Our findings are four-fold. First, the relative risk (RR) of disabled people was 5.075 (95% confidence interval 4.476-5.674), significantly surpassing that of non-disabled people, 3.296 (2.517-4.075). Second, among various personal characteristics studied, disability influenced RR the most, exceeding impacts from elderly (4.457: 3.748-5.166), low-income (3.909: 3.004-4.813), and outdoor (4.052: 2.940-5.164). Third, the disabled young group (5.305: 4.414-6.195) was more vulnerable than the non-disabled elderly group (4.287: 3.576-4.999). Lastly, no significant difference in relative risk was observed between the mild (4.413: 3.855-4.971) and severe disabled groups (4.013: 3.121-4.905).

Muscle Mass Changes After Daily Consumption of Protein Mix Supplemented With Vitamin D in Adults Over 50 Years of Age: Subgroup Analysis According to the Serum 25(OH)D Levels of a Randomized Controlled Trial.

Early prevention of sarcopenia can be an important strategy for muscle maintenance, but most studies target subjects at slightly pre-sarcopenic state. Our previous paper describes the effect of protein supplements rich in leucine and vitamin D on muscle condition, and in this paper, we performed a sub-analysis to evaluate who benefitted the most in terms of improvement in muscle health. A 12-week randomized clinical trial of 120 healthy adults (aged 50 to 80) assigned to an intervention group (n = 60) or control group (n = 60) were analyzed. Subjects in the intervention group received, twice per day, a protein supplement containing (per serving) 800 IU of vitamin D, 20 g of protein (3 g of total leucine), 300 mg of calcium, 1.1 g of fat, and 2.5 g of carbohydrate. The subjects were classified into 'insufficient' and 'sufficient' groups at 25-hydroxyvitamin D (25[OH]D) value of 30 ng/mL. The skeletal muscle mass index normalized to the square of the skeletal muscle mass (SMM) height (kg/m2) increased significantly in the 'insufficient group' difference value of change between weeks 0 and 12 (Δ1.07 ± 2.20; p = 0.037). The SMM normalized by body weight (kg/kg, %) was higher, but not significantly, in the insufficient group (Δ0.38 ± 0.69; p = 0.050). For people with insufficient (serum 25[OH]D), supplemental intake of protein and vitamin D, calcium, and leucine and adequate energy intake increases muscle mass in middle-aged and older adults and would be likely to exert a beneficial effect on muscle health. Trial Registration: Clinical Research Information Service Identifier: KCT0005111.

Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS).

Duloxetine and thioctic acid (TA) are standard drugs for treating diabetic neuropathy, a primary complication associated with diabetes. In this study, ultra performance liquid chromatography coupled with tandem mass spectrometry methods was successfully developed and validated for quantifying duloxetine and TA in biological samples. The protein precipitation method was used to extract duloxetine, TA and their internal standards from beagle dog plasma. A Hypersil Gold C18 column (150 × 2.1 mm, 1.9 µm) was used for the experiment. Isocratic elution with 0.1% formic acid in acetonitrile (A) and 0.1% formic acid (B) was used for duloxetine, whereas a gradient elution with 0.03% acetic acid (A) and acetonitrile (B) was used for TA. The validated parameters included linearity, sensitivity, accuracy, precision, selectivity, matrix effect, stability, and recovery under different conditions. The linear ranges of the calibration curves for duloxetine and TA were 5-800 ng/mL and 5-1,000 ng/mL, respectively. An intra- and inter-run precision of ± 15% can be observed in all quality control samples. These methods were successfully used for pharmacokinetics (PKs) studies in beagle dogs to compare PK differences in a fixed-dose combination including duloxetine and TA and co-administration of the 2 drugs.

Musculoskeletal Health of the Adults Over 50 Years of Age in Relation to Antioxidant Vitamin Intakes.

As the proportion of the elderly population increases rapidly, interest in musculoskeletal health is also emerging. Here, we investigated how antioxidant vitamin intake and musculoskeletal health are related. Adults aged 50 to 80 years with a body mass index (BMI) of 18.5 to 27.0 kg/m2 were included. Bone mineral density (BMD), lean mass (LM), appendicular skeletal muscle mass index (ASMI) were measured using dual-energy X-ray absorptiometry (DXA), and the grip strength and knee extension using hand dynamometer. Nutrient intakes were measured using a 24-hour recall questionnaire. A total of 153 adults (44 men and 109 women) participated in this study. A partial correlation analysis showed a significant positive relationship between vitamin E and BMD and between vitamin C and LM/Height. Participants were classified into three groups according to whether their vitamin E and C intake met the recommended intake for Dietary Reference Intakes for Koreans (KDRIs). The prevalence of having low T-score (< -1.0) and low ASMI (< 7.0 for men and < 5.4 for women) was 51.3% and 15.4% in the group with vitamins C and E intakes below KDRIs. After adjusting for sex, smoking status and energy, protein, vitamin D, and calcium intake, the group with vitamins C and E both below the KDRIs displayed a significantly lower BMD at all test sites and LM/Height compared with vitamin C and/or E intake above the KDRIs groups. We conclude that sufficient intake of vitamin E and C is important for maintaining BMD and lean mass in Korean adults over 50 years of age.

Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

The blood-brain barrier (BBB) is composed of specific tight junction proteins and transporters expressed on the lining of endothelial cells of the vasculature in the brain. The structural and functional integrity of the BBB is one of the most critical factors for maintaining brain homeostasis and is mainly regulated by complex interactions between various cell types, such as endothelial cells, pericytes, and astrocytes, which are shaped by their differential responses to changes in microenvironments. Alterations in these cellular components have been implicated in neurodegenerative disorders. Although it has long been considered that BBB dysfunction is a mere ramification of pathological phenomena, emerging evidence supports its critical role in the pathogenesis of various disorders. In epilepsy, heightened BBB permeability has been found to be associated with increased occurrence of spontaneous seizures. Additionally, exaggerated inflammatory responses significantly correlate with increased BBB permeability during healthy aging. Furthermore, it has been previously reported that BBB disruption can be an early marker for predicting cognitive impairment in the progression of Alzheimer's disease. We herein review a potential role of the major cellular components of the BBB, with a focus on the contribution of BBB disruption, in neurodegenerative disease progression.

Bioanalytical Method Using Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPL-CHRMS) for the Detection of Metformin in Human Plasma.

Metformin is the first-line medicine for the treatment of type 2 diabetes. Drug interactions between metformin and other drugs, food, or beverages cannot only cause changes in the pharmacokinetic profiles but also affect the efficacy of metformin. The purpose of this study was to develop a rapid and reliable bioanalytical method for the detection of plasma metformin concentration in humans. To remove interfering substances in plasma, acidified acetonitrile (acetonitrile containing 0.1% formic acid) was added to samples. Ultra-high-performance liquid chromatography (UHPLC) coupled with high resolution mass spectrometry (HRMS) was used to analyze metformin and its internal standard (metformin-d6). Analyte separation was performed on a BEH HILIC analytical column (100 × 2.1 mm, 1.7 µm) using a gradient elution of 0.1% formic acid (A) and acetonitrile with 0.1% formic acid (B). The total chromatographic run time was 2 min. The developed method was validated for its linearity, accuracy and precision, selectivity (signal of interfering substance; analyte, lower limit of quantification (LLOQ) ≤ 20%; IS, IS ≤ 5%), sensitivity (LLOQ, 5 ng/mL; S/N ratio ≥ 10), stability (low quality control (LQC, 15 ng/mL), 2.95-14.19%; high quality control (HQC, 1600 ng/mL), -9.49-15.10%), dilution integrity (diluted QC (4000 ng/mL); 10-folds diluted QC (400 ng/mL); 5-folds diluted QC (800 ng/mL); accuracy, 81.30-91.98%; precision, ≤4.47%), carry-over (signal of double blank; analyte, LLOQ ≤20%; IS, IS ≤5%), and matrix effect (LQC, 10.109%; HQC, 12.271%) under various conditions. The constructed calibration curves were shown linear in the concentration range of 5-2000 ng/mL, with within- and between-run precision values of <8.19% and accuracy in the range of 91.13-105.25%. The plasma metformin concentration of 16 healthy subjects was successfully measured by applying the validated bioanalytical method.

Electrochemical Descaling of Metal Oxides from Stainless Steel Using an Ionic Liquid-Acid Solution.

Oxide scales often formed on the surface of stainless steel, and it is of high interest to descale the surface oxide effectively and environment-friendly during steel smelting and engineering processing. It is generally done by treating the oxide layer under strong and harsh mixed acid (HNO3 + HF) conditions or in a strong molten salt (NaOH + NaNO3) environment at high temperatures, while the generation of very harmful and environmentally hazardous gases, such as NO x , is inevitable. A novel, simple, fast, and environment-friendly electrochemical method at ambient temperature is proposed in this research to remove the oxide scale from the stainless steel surface using an ionic liquid with a small amount of HCl. It was found that the optimized electrochemical anodization treatment in an ionic liquid environment could significantly improve the descaling efficiency at least 50 times faster than the simple passive and slow dissolution in a mixture of an ionic liquid and a concentrated acid.

Leucine-Enriched Protein Supplementation Increases Lean Body Mass in Healthy Korean Adults Aged 50 Years and Older: A Randomized, Double-Blind, Placebo-Controlled Trial.

Early prevention of sarcopenia could be an important strategy for muscle retention, but most studies have focused on subjects aged 65 or older. Therefore, in this study we investigated the effects of leucine-enriched protein supplementation on muscle condition in a sample including late middle-aged adults. A 12-week intervention was performed for 120 healthy community-dwelling adults by providing either leucine-enriched protein supplement [leucine 3 g, protein mixture (casein 50% + whey 40% + soy 10%) 17 g, vitamin D 800IU (20 µg), calcium 300 mg, fat 1.1 g, carbohydrate 2.5 g] or isocaloric carbohydrate supplement twice per day. Appendicular skeletal muscle mass index (ASMI) and lean body mass (LBM) were measured by dual-energy X-ray absorptiometry. A total of 111 participants completed the study, with a dropout rate of 9.2%. LBM normalized by height and body weight (LBM/Wt) was significantly increased (p < 0.001) in the intervention group (0 wk: 633.9 ± 8.5 vs. 12 wk 636.9 ± 8.4 in the intervention group; 0 wk: 638.6 ± 8.3 vs. 12 wk: 632.9 ± 8.1 in the control group). In subgroup analyses, significant differences remained only in subjects between 50 and 64 years of age. We concluded that leucine-enriched protein supplementation can have beneficial effects by preventing muscle loss, mainly for late middle-aged adults.

Determination of Serotonin Concentration in Single Human Platelets through Single-Entity Electrochemistry.

This research introduces a method to directly detect serotonin in a single platelet through single-entity electrochemistry. Platelets isolated from human blood were analyzed by cyclic voltammetry and current-time measurements. When a single platelet collides with an ultramicroelectrode, serotonin inside the platelet is oxidized at the electrode surface, and an anodic current peak is consequently observed during measurement. The concentration of serotonin can be determined by integrating this peak current. In addition, this method can be used to determine the platelet concentration. Analysis of the collision frequency of platelets can provide information about the platelet concentration in the blood. As a result, platelet levels and serotonin concentrations in single platelets can be measured quickly and easily.

Factors that determine thione(thiol)-disulfide interconversion in a bis(thiosemicarbazone) copper(ii) complex.

Solvent-, acidity-, and redox-responsive thione(thiol)-disulfide interconversion were achieved by a dinuclear copper(ii) complex bearing a bis(thiosemicarbazone) (bTSC) ligand. The role of copper(ii) ion coordination was rationalized by parallel comparison with a bare bTSC ligand and zinc(ii) bTSC complexes under identical reaction conditions.

Transition metal doped Sb@SnO2 nanoparticles for photochemical and electrochemical oxidation of cysteine.

Transition metal-doped SnO2 nanoparticles (TM-SnO2) were synthesized by applying a thermos-synthesis method, which first involved doping SnO2 with Sb and then with transition metals (TM = Cr, Mn, Fe, or Co) of various concentrations to enhance a catalytic effect of SnO2. The doped particles were then analyzed by using various surface analysis techniques such as transmission electron microscopy (TEM), X-ray diffraction (XRD), scanning transmission X-ray microscopy (STXM), and high-resolution photoemission spectroscopy (HRPES). We evaluated the catalytic effects of these doped particles on the oxidation of L-cysteine (Cys) in aqueous solution by taking electrochemical measurements and on the photocatalytic oxidation of Cys by using HRPES under UV illumination. Through the spectral analysis, we found that the Cr- and Mn-doped SnO2 nanoparticles exhibit enhanced catalytic activities, which according to the various surface analyses were due to the effects of the sizes of the particles and electronegativity differences between the dopant metal and SnO2.